McAdam LLC’s VivoSim Labs VIVS Stock Holding History

McAdam LLC’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	–	–	646
2018 Q3	$0	Hold	1	–	–	﹤0.01%	747
2018 Q2	$0	Hold	1	–	–	﹤0.01%	835
2018 Q1	$0	Buy	+1	New	+$292	﹤0.01%	812

Other funds holding VIVS

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

McAdam LLC's VIVS Position: Q4 2018 in Review

McAdam LLC sold out of VivoSim Labs (VIVS) in Q4 2018, closing a stake of 1 share.

McAdam LLC first reported a position in VIVS in Q1 2018 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 114 funds tracked by Wall St. Rank hold VIVS as of Q4 2018.

McAdam LLC reported no remaining VivoSim Labs position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 1 VivoSim Labs share in Q4 2018.
McAdam LLC first reported a position in VivoSim Labs in Q1 2018 and held it in 3 quarters.
McAdam LLC's VivoSim Labs position peaked at $0 in Q3 2018.
114 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.